Schedule 13G ownership disclosure

DEPOMED INC

Security class unavailable · CUSIP: 249908104

Event date: 2014-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,163,828
Percent of class
5.3700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-15-000984
Form type
SC 13G/A
Filer
Assertio Therapeutics, Inc
CIK
CIK 1005201
Filed
Feb 17, 2015
Reporting period
Dec 31, 2014
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub